Independent mechanisms for macrophage binding and macrophage phagocytosis of damaged erythrocytes - Evidence of receptor cooperativity

被引:41
作者
Sambrano, GR [1 ]
Terpstra, V [1 ]
Steinberg, D [1 ]
机构
[1] Univ Calif San Diego, Dept Med 0682, La Jolla, CA 92093 USA
关键词
macrophages; apoptosis; scavenger receptors;
D O I
10.1161/01.ATV.17.12.3442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The binding and phagocytosis of oxidatively damaged red blood cells (OxRBCs) by mouse peritoneal macrophages can be inhibited by oxidatively modified LDL (OxLDL), implying some commonality at their receptor-binding domains. Studies from many different laboratories support the view that OxRBC binding is due to the disruption of plasma membrane phospholipid asymmetry and the subsequent exposure of phosphatidylserine (PS) on the outer membrane leaflet. Presumably, oxidation of LDL creates a surface structure on it in some way homologous to the PS-rich domain on OxRBCs. Apoptotic cells in some instances are also recognized because of PS exposure on the outer leaflet of the membrane, and apoptotic cells are a common feature of atherosclerotic lesions. In the present studies, the mechanisms of binding and internalization of cells recognized by virtue of their membrane PS were studied using OxRBCs or vanadate-treated erythrocytes (VaRBCs) as models. Disruption of phospholipid asymmetry with vanadate produced cells that were bound by macrophages in the same divalent cation-dependent manner as OxRBCs. However. whereas OxRBCs were rapidly phagocytosed, VaRBCs were not. Stimulation of mouse macrophages with phorbol myristate acetate resulted in a concentration-dependent induction of phagocytosis of bound VaRBCs, on effect that could be prevented by the protein kinase C inhibitor staurosporine. Because phagocytosis of OxRBCs occurred unassisted, we speculated that there must be additional membrane changes induced by oxidation (over and above the disruption of phospholipid asymmetry) that contribute to phagocytosis of OxRBCs, possibly resulting in the ligation of a distinct receptor chat does not necessarily contribute to adherence. This proposal is supported by the finding that ligation of macrophage Fc gamma receptors by the anti-Fc gamma RII/RIII antibody 2.4G2 triggers the phagocytosis. of bound VaRBCs. Phagocytosis is also triggered by subthreshold opsonization of VaRBC, ie, by antibody concentrations that do not by themselves cause binding and phagocytosis of native RBCs. Finally, treatment: with low concentrations of glutaraldehyde, which causes membrane protein cross-linking, promotes the phagocytosis of VaRBCs, but, at the low concentration used, has little or no effect on binding and phagocytosis of native RBCs. We that the internalization of damaged cells, bound because of PS exposure, requires the cooperation of a PS-binding receptor with at lease one additional receptor to trigger an intracellular signaling pathway to initiate phagocytosis.
引用
收藏
页码:3442 / 3448
页数:7
相关论文
共 41 条
[1]  
BARTOSZ G, 1990, BLOOD CELL BIOCH, V1, P45
[2]   DEGRADATION OF CATIONIZED LOW-DENSITY LIPOPROTEIN AND REGULATION OF CHOLESTEROL-METABOLISM IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA FIBROBLASTS [J].
BASU, SK ;
GOLDSTEIN, JL ;
ANDERSON, RGW ;
BROWN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3178-3182
[3]   BINDING AND PHAGOCYTOSIS OF APOPTOTIC VASCULAR SMOOTH-MUSCLE CELLS IS MEDIATED IN PART BY EXPOSURE OF PHOSPHATIDYLSERINE [J].
BENNETT, MR ;
GIBSON, DF ;
SCHWARTZ, SM ;
TAIT, JF .
CIRCULATION RESEARCH, 1995, 77 (06) :1136-1142
[4]   APOPTOSIS OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM NORMAL VESSELS AND CORONARY ATHEROSCLEROTIC PLAQUES [J].
BENNETT, MR ;
EVAN, GI ;
SCHWARTZ, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2266-2274
[5]  
Bjorkerud S, 1996, AM J PATHOL, V149, P367
[6]  
COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
[7]  
DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.biophys.21.1.417
[8]   ROLE OF MEMBRANE RECEPTORS FOR C3B AND C3D IN PHAGOCYTOSIS [J].
EHLENBERGER, AG ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 145 (02) :357-371
[9]  
FADOK VA, 1992, J IMMUNOL, V149, P4029
[10]  
FADOK VA, 1992, J IMMUNOL, V148, P2207